This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for PfizerThe Motley Fool • 07/24/24
Pfizer's hemophilia A gene therapy found superior to current treatment in late-stage trialReuters • 07/24/24
Pfizer announces positive results from late-stage trial of Hemophilia A treatmentMarket Watch • 07/24/24
Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy CandidateBusiness Wire • 07/24/24
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026Benzinga • 07/18/24
Is Pfizer Stock A Buy After Breaking Out On Obesity Treatment Fervor?Investors Business Daily • 07/18/24
Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology PortfolioBenzinga • 07/18/24
Time to Pounce: 2 Beaten-Down Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought Right NowThe Motley Fool • 07/18/24
Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series CompletionGlobeNewsWire • 07/17/24
European Commission didn't provide enough information about COVID-19 vaccine deals, EU court saysMarket Watch • 07/17/24
Forget Medical Properties Trust: This High-Yielding Dividend Stock Is a Much Better BuyThe Motley Fool • 07/16/24